Pharmaceutical group
A group of 6 companies with 1,689 medicines in 6 countries.
6 companies in 4 countries
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Every medicine of every company in the group, current ones first.
1โ25 of 1,689
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| Abirateron Pharmascience 500 mg filmom obloลพene tableteFilmom obloลพena tableta | Abiraterone | Croatia | Marketed | 2026 |
| ACETAMINOPHEN EXTRA STRENGTH500 mg ยท Tablet | Paracetamol | Canada | Authorised | |
| ACID CONTROLLER MAXIMUM STRENGTH20 mg ยท Tablet | Famotidine | Canada | Authorised | |
| AEROFRIN | Salbutamol | Brazil | Authorised | 1999 |
| ALLERGY CONTROL DESLORATADINE5 mg ยท Tablet | Desloratadine | Canada | Authorised | |
| ALLERGY FORMULA25 mg ยท Tablet | Diphenhydramine | Canada | Authorised | |
| ANALGESIC AND MUSCLE RELAXANT400 mg + 500 mg ยท Tablet | Ibuprofen, Methocarbamol | Canada | Not marketed | 2012 |
| ANTI-NAUSEANT50 mg ยท Tablet | Dimenhydrinate | Canada | Authorised | |
| APETIVAN BC | Ciproeptadina, Vitamin b1, Vitamin b2, Vitamin b6, Nicotinamide, Ascorbic acid | Brazil | Authorised | 1999 |
| ARTHRITIS PAIN RELIEF650 mg ยท Tablet (Extended-Release) | Paracetamol | Canada | Not marketed | 2022 |
| ASA81 mg ยท Tablet (Delayed-Release) | Acetylsalicylic acid | Canada | Marketed | 2015 |
| ASA 81 MG81 mg ยท Tablet (Delayed-Release) | Acetylsalicylic acid | Canada | Marketed | 2001 |
| ASA DAILY LOW DOSE81 mg ยท Tablet (Chewable) | Acetylsalicylic acid | Canada | Marketed | 2013 |
| ASAPHEN80 mg ยท Tablet (Chewable) | Acetylsalicylic acid | Canada | Marketed | 1995 |
| ASAPHEN E.C. 80 MG80 mg ยท Tablet (Delayed-Release) | Acetylsalicylic acid | Canada | Marketed | 1998 |
| ASAPHEN PLUS 325325 mg ยท Tablet | Acetylsalicylic acid | Canada | Authorised | |
| Azacitidin Pharmascience 25 mg/ml praลกak za suspenziju za injekcijupraลกak za suspenziju za injekciju | Azacitidine | Croatia | Not marketed | 2025 |
| AZITROMICINA | Azithromycin | Brazil | Authorised | 2009 |
| BENZOYL PEROXIDE LOTION5 % ยท Lotion | Benzoyl peroxide | Canada | Authorised | |
| BIOHEPATON | Peumus boldus molina | Brazil | Authorised | 2010 |
| CALMLIVE | Passiflora incarnata l. | Brazil | Authorised | 2025 |
| CLARILAX1 g / g ยท Powder For Solution | Macrogol | Canada | Authorised | |
| cloridrato de fluoxetina | Fluoxetine | Brazil | Authorised | 2015 |
| cloridrato de loperamida | Loperamide | Brazil | Authorised | 2025 |
| COLACE10 mg / ml ยท Solution | Docusate | Canada | Marketed | 1996 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Canada | 1,373 | 674 | 699 | CompaniesAll medicines |
| Brazil | 266 | 125 | 141 | CompaniesAll medicines |
| Croatia | 29 | 29 | 0 | CompaniesAll medicines |
| Saudi Arabia | 18 | 18 | 0 | CompaniesAll medicines |
| Netherlands | 2 | 2 | 0 | CompaniesAll medicines |
| United States | 1 | 0 | 1 | CompaniesAll medicines |
Also in the registers of Colombia, Serbia, Singapore, United Kingdom
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
ANVISA / CMED, consumer price table; embedded source date 2026-07-21 and retrieval date
Licence: Other (Public Domain)
Anvisa published factual open-data CSV https://dados.anvisa.gov.br/dados/CONSULTAS/PRODUTOS/TA_CONSULTA_MEDICAMENTOS.CSV, HTTP version Mon, 12 Oct 2026 11:45:25 GMT; acquired 12 October 2026; original source states and timestamps retained.
Licence: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions
Anvisa, https://dados.anvisa.gov.br/dados/CONSULTAS/EMPRESA_FISCALIZACAO_PRODUTO/TA_CONSULTA_CBPF_MEDICAMENTO_DETALHE.CSV; source modified Fri, 15 May 2026 07:52:35 GMT; acquired 2026-10-18T08:23:43.211112+00:00; original factual values retained, no endorsement.
Licence: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Agรชncia Nacional de Vigilรขncia Sanitรกria (Anvisa), DATAVISA open-data register; source modification 2026-10-07, acquired 2026-10-07 UTC.
Licence: Brazil federal open-data reuse, Decreto 8777/2016, consolidated article 4 as amended by Decreto 9903/2019
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM otros; source update 2026-09-16; acquired 2026-10-08.
Licence: CC BY-SA 4.0
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM vencidos; source update 2026-09-16; acquired 2026-10-08.
Licence: CC BY-SA 4.0
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 1 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:47.757811+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Report an error or request removalCorrections from the company itself are welcome.
Keep Pharmascienceโs medicines accurate on Prognia, see how professionals use them and answer what they ask. A 20-minute call, in English.
Book a callHALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Licence: Otvorena dozvola RH
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
ALIMS, Registar humanih lekova, source 08.10.2026 02:00, downloaded 2026-10-08, https://data.gov.rs/sr/datasets/lekovi-za-upotrebu-u-khumanoj-meditsini/; structured factual adaptation; Serbian Open Data Licence.
Licence: Serbian Open Data Licence (sodl)
Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Licence: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Licence: Singapore Open Data Licence
Well-known pharmaceutical groups, each with all its companies.
